Combination product composed of pyrimido-pyrimidines and O-acety

Details Combination product composed of pyrimido-pyrimidines and O-acety Combination product composed of pyrimido-pyrimidines and O-acety

1985-07-19

1987-09-15

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ortho-hydroxybenzoic acid or derivative doai

A61K 3162

Patent

active

046940243

ABSTRACT:
O-acetylsalicylic acid and a pyrimido-pyrimidine as combination products.

REFERENCES:
Bye et al., British Journal of Clinical Pharmacology, 7: 283-286, (1979).
Canadian Cooperative Study Group, New England Journal of Medicine, 299: 53-59, (1978).
Roth and Majerus, Journal of Clinical Investigation, 56: 624-632, (1975).
Basista, et al., Pharmacological Research Communications, 10: 759, (1978).
Masotti et al., The Lancet, iii: 1213-1216, (1979).
Shaikh et al., Prostaglandins and Medicine, 4: 439-447, (1980).
McDonald et al., Prostaglandins, Leukotrines and Medicine, 12: 235-244, (1983).
Platelets and Thrombosis, Mills and Pareti (Eds.), pp. 175-179, Academic Press (1977).
Kadatz et al., Herz-Kreislauf, 12: 519-524, (1973).
Van de Velde, Arch. Int. Pharmacodyn., 256: 327-328.
Brantmark et al., European Journal of Clinical Pharmacology, 22: 309-314, (1982).
Duggan, British Journal of Clinical Pharmacology, 10 (Supp. 2) (1980).
International Meeting on Side Effects of Anti-Inflammatory, Analgesic Drugs (Verona), Sep. 13-15, 1982, (Abstracts).
Goodman and Gilmans The Pharmacological Basis of Therapeutics, (6th Ed.), p. 830.
Wagner, Drug Intelligence Publications, (1st Ed.), pp. 158-165, (1971).
Day et al., Australia and New Zealand Journal of Medicine, 6: 45-50, (1976).
Orozco-Alcala and Baum, Arthitis and Rheumatism, 22: 1034-1037, (1979).
Anslow et al., Current Therapeutic Research, 36: 811-818, (1984).
Leonards, Journal of the American Medical Assoc., 193: 93-98, (1965).
Anslow et al., Pharmacology, 30: 40-44, (1985).
Baum, Journal of Rheumatology, 11: 250-251, (1984).
Bogentoft et al., European Journal of Clinical Pharmacology, 14: 351-355, (1978).
Roberts et al., European Journal of Clinical Pharamcology, 27: 67-74, (1984).
Arfors et al., Nature, 218: 887-888, (1968).
Weichert et al., Haemostasis, 13: 61, (1983).
Seiffge and Dremer, IRCS Medical Science, 12: 91-92, (1984).
Cavalli-Sforza, Biometrie, pp. 49 et seq., (Stuttgart, 1969).
Villa and de Gaetano, Thrombosis Research, 15: 727-732, (1979).
Honour et al., British Journal of Experimental Pathology, 58: 268-272, (1977).
Viinikka and Ylikorkala, British Journal of Pharmacology, 72: 299-303, (1981).
Buchanan et al., Increased Dipyridamole Plasma . . . in vivo., Chemical Abstracts, 92: 15588w (1980).
Steele, Trial of Dipyridamole-Aspirin . . . Thrombosis, Chemical Abstracts, 94: 132512u, (1981).
Smith, Dipyridamole may be more Effective . . . Aspirin, Chemical Abstracts, 95: 108636n, (1981).
Kirchmaier et al., Thrombosis Inhibiting Effect . . . Dipyridamole, Chemical Abstracts, 95: 197335d, (1981).
Buchanan et al., Increased Dipyridamole Plasma Concentrations . . . In Vivo, Thrombosis Research 15, 813-820.
Chem. Abst., (92), 518800+51916k, (1980).
Chem. Abst., (95), 651z, (1981).

Affiliated with

Also associated with

Rating

Combination product composed of pyrimido-pyrimidines and O-acety does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination product composed of pyrimido-pyrimidines and O-acety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination product composed of pyrimido-pyrimidines and O-acety will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1385287